Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

New procedure for treating achalasia to reduce reflux

Official title: Per-oral Endoscopic Myotomy With Fundoplication for Achalasia - an International Multicenter Randomized Controlled Trial

Run by Chinese University of Hong Kong · NCT06042127 · Data updated 2026-11-12

This study is testing a new procedure for treating achalasia to see if it can reduce the chance of reflux in adults who have trouble swallowing.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment81 (estimated)
SponsorChinese University of Hong Kong
Academic / other
Locations7 sites (Baltimore, Maryland and 6 other locations)
StatusRecruiting
StartedDecember 1, 2023
Main results expectedOctober 31, 2025
Study endsOctober 31, 2026
Registry record updatedDecember 3, 2024
Trial IDNCT06042127 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 to 65 with symptomatic achalasia types I or II, who are either treatment naïve or have failed prior balloon dilation treatments.

Probably not a fit

Patients with previous esophageal or gastric surgery, or those with significant comorbidities that may limit their ability to participate, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This international multicenter study investigates the efficacy of a novel procedure called per-oral endoscopic myotomy with fundoplication (POEM-F) for treating achalasia, a condition characterized by difficulty swallowing. The study aims to compare the incidence of gastroesophageal reflux disease (GERD) between patients undergoing POEM-F and those receiving conventional POEM. By performing both procedures in the same session, the researchers hope to minimize the risk of GERD, which is a common complication of POEM. The study will include adult patients aged 18 to 65 with symptomatic achalasia types I or II, and will assess outcomes through various questionnaires and clinical evaluations.

Why it matters

Potential benefit: If successful, this approach could significantly reduce the incidence of GERD in patients undergoing treatment for achalasia.

How similar studies have gone: While POEM has been established as an effective treatment for achalasia, the specific combination of POEM-F is novel and has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria:

1. Adult patient (age ≥18 and ≤65 years-old) and with symptomatic achalasia type I or II.
2. Capability of understanding and complying with the study requirements, including filling the Eckardt Score, GERD-HRQL and RSI questionnaire and signing the informed consent form.
3. Patients with achalasia type I, II or III who are one of the following:

   * Treatment naïve, or
   * Failed prior through-the-scope balloon dilation, Savary or pneumatic dilation

Exclusion criteria:

1. Patients unable or unwilling to provide consent.
2. Previous esophageal or gastric surgery.
3. Prior achalasia treatment including Heller myotomy, POEM.
4. Sigmoid achalasia, or significant esophageal dilatation \>6cm in lower esophagus
5. Disrupted mucosal integrity at the distal esophagus, eg. Ulcer, fibrotic scars etc
6. Patients with large hiatal hernias (axial length \> 2 cm and Hill grade \>2).
7. Patients with significant cardiorespiratory comorbidities which may limit their ability to undertake general anesthesia for the procedure, including ASA grade III or above.
8. Patients with obesity (Body Mass Index (BMI) ≥ 30).
9. Pregnant women or those planning pregnancy or breastfeeding women.
10. Uncorrectable coagulopathy defined by international normalized ratio (INR) \> 1.5 or platelet count \< 50000/µl.

Where it's running

  • The Chinese University of Hong Kong
    Hong Kong, Hong Kong
    Recruiting
  • Johns Hopkins Hospital
    Baltimore, Maryland, United States
    Not yet recruiting
  • Nanfang Hospital, Southern Medical University
    Guangzhou, China
    Not yet recruiting
  • Post Graduate Institute of Medical Education and Research
    Chandigarh, India
    Not yet recruiting
  • Asian Institute of Gastroenterology
    Hyderabad, India
    Not yet recruiting
  • Baldota Institute of Digestive Sciences
    Mumbai, India
    Not yet recruiting
Show 1 more location
  • Deenanath Mangeshkar Hospital & Research Center
    Pune, India
    Not yet recruiting

Study contacts

  • Principal investigator: Hon Chi Yip, FRCSEd — Chinese University of Hong Kong
  • Study coordinator: Hon Chi Yip, FRCSEd
  • Email: hcyip@surgery.cuhk.edu.hk
  • Phone: 35052627

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.